Opinions on Biotechnology

Opinion 24 Mar 2023

PAN-TB regimens to address growing TB drug resistance

By Dr. Charles Wells, head of therapeutics development at Gates Medical Research Institute As nearly one-quarter of the world’s population…

March 24, 2023 - 5 minutesmins - By External Contributor

Opinion 8 Mar 2023

Should pharma be listening to social media to drive drug development?

By Thierry Escudier, consultant and strategic leader at The Pistoia Alliance The move towards patient centricity is gathering momentum, and…

March 8, 2023 - 5 minutesmins - By External Contributor

Opinion 28 Feb 2023

Life changing treatments for rare disease – a beacon of hope

By Sander Slootweg, managing partner, Forbion More than 300 million people around the globe are affected by a rare disease.…

February 28, 2023 - 6 minutesmins - By External Contributor

Opinion 9 Feb 2023

How AI and ML can transform clinical research

By Gary Shorter, head of artificial intelligence at IQVIA Clinical trials are currently in an era of transformation through digitization,…

February 9, 2023 - 4 minutesmins - By External Contributor

Opinion 3 Feb 2023

AI and experiments: new possibilities emerge in 2023

By Markus Gershater, co-founder and chief scientific officer, Synthace The buzz surrounding generative AI has reached fever pitch. It’s a…

February 3, 2023 - 5 minutesmins - By External Contributor

Opinion 2 Feb 2023

How digital biomarker assays can harness the power of deep learning from clinical trials to the clinic

By Joe Oakley, MD, medical director of biomarker development, Paige Just as much of medicine has begun to undergo a…

February 2, 2023 - 8 minutesmins - By External Contributor

Opinion 1 Feb 2023

How AI is reshaping cancer diagnosis and treatment

By Soheila Borhani, School of Biomedical Informatics, University of Texas Health Science Center Since its first documented case circa 3000…

February 1, 2023 - 4 minutesmins - By Jim Cornall

Opinion 1 Feb 2023

Computational chemistry and cancer

by Martin Slater, Cresset Discovery Computational chemistry offers a fast and innovative approach to drug discovery and is especially powerful…

February 1, 2023 - 3 minutesmins - By External Contributor

Opinion 18 Jan 2023

Innovation in life sciences requires collaboration and community

By Claudia Tripp and Katie Nelson, Kadans Science Partner Collaboration has underpinned some of the most impactful innovations of recent…

January 18, 2023 - 5 minutesmins - By External Contributor

Opinion 12 Dec 2022

Artificial intelligence: a new era in rare genetic disease diagnosis

Despite the onset of the genomics era, rare disease diagnosis remains a challenge. Nostos Genomics’ co-founder, Rocío Acuña Hidalgo, and…

December 12, 2022 - 6 minutesmins - By External Contributor

Opinion 25 Oct 2022

Precision medicine research must lose its Eurocentricity

Precision medicine research relies on genetic testing at scale, but how do we reach more diverse patient populations and collect…

October 25, 2022 - 7 minutesmins - By External Contributor

Opinion 24 Oct 2022

Hiding in plain sight: how to solve bioscience’s software problem

Guy Levy-Yurista, CEO of the experiment platform developer Synthace, gives his take on what’s missing in increasingly software-dependent life sciences…

October 24, 2022 - 5 minutesmins - By External Contributor

News and Trends 20 Oct 2022

The role of long-read sequencing in validating CRISPR outcomes

Neil Ward, general manager of PacBio EMEA With applications of CRISPR across the spectrum of microbial, plant and gene therapy…

October 20, 2022 - 3 minutesmins - By External Contributor

Opinion 6 Sep 2022

Meeting tech transfer challenges when manufacturing new biopharmaceuticals

With increasingly complex therapeutics arriving almost monthly, efficient technology transfer between biopharma and manufacturers is more important than ever. Ken…

September 6, 2022 - 7 minutesmins - By External Contributor